October 26-28, 2008
Hyatt Regency Cambridge
President's Ballroom
Welcome
General InformationThe National Cancer Institute (NCI) has made a strong commitment to support the development and application of new technologies in the nation's continuing battle against cancer. Since 1999, the Innovative Molecular Analysis Technologies (IMAT) program has been a central part of this effort, supporting technologies specifically of interest for cancer research that include technologies for analysis in vitro, in living cells, and in the body. The IMAT initiative also includes grantees for the Application of Emerging Technologies for Cancer Research and Innovations in Cancer Sample Preparation programs. We are very pleased to invite you to participate in the NCI's Ninth Principal Investigators (PI) Meeting for the IMAT program to be held on October 26-28, 2008 at the Hyatt Regency Cambridge.
Description
The intent of the PI meeting is to provide the opportunity for participants in this program to share their ideas and progress. This meeting will also provide a forum to discuss research and potential collaborations with investigators representing a broad range of scientific expertise. In addition, we would like to use this opportunity to share information with you on complementary NCI programs and NCI research resources, as well as to solicit your ideas on how the NCI can facilitate your progress, and progress in general, in developing new molecular analysis technologies for cancer research.
In accordance with guidelines in the grant, all principal investigators are expected to personally participate in the meeting utilizing the budgetary resources allocated for travel in their original IMAT applications. In the unfortunate event that previous commitments preclude your attendance, we would recommend the attendance of an appropriate senior member of your research team. We appreciate that for some projects critical direction is also being provided by a co-PI, and will consider requests for the attendance of this investigator as a second representative of the project at the meeting. These requests should be addressed to Richard Aragon, Ph.D. at raragon@mail.nih.gov or (301) 435-3877. In general, we are limiting attendance to the PI on the award.
For each funded project, the principal investigator should submit an abstract for poster presentation. A limited number of projects will be selected for oral presentation at the meeting based on the abstracts. We appreciate that some of the projects have only recently been awarded, and recommend that posters for these projects, in lieu of limited preliminary data, focus on the technology proposed and plans for the future.
Back to Top
